ARG1 and neoplasm: Despite there being no difference between exosomal Arg-1 levels of HDs and HNSCC patients, the levels within the HNSCC patient group showed significant differences depending on the presence of lymph node metastasis, providing evidence for the possible usage of exosomes as markers for HNSCC tumor aggressiveness.